格隆匯APP獲悉,根據聯交所最新權益披露資料顯示,2022年2月17日,泰格醫藥(03347.HK)獲Aggregate of abrdn plc affiliated investment management entities在場內以每股均價86.3639港元增持22.51萬股,涉資約1944.05萬港元。
增持後,Aggregate of abrdn plc affiliated investment management entities最新持股數目為873.02萬股,持股比例由6.91%上升至7.09%。